期刊文献+

应用基因芯片技术研究肝癌组织特异性候选基因

Analysis of tissue-specific candidate genes in hepatocellular carcinoma by gene chips
原文传递
导出
摘要 目的筛选肝癌组织特异性癌症相关候选基因。方法应用基因芯片技术检测肝癌细胞系Bel7402-2、肾癌细胞系KETR、胃癌细胞系SGC基因及人胎肝细胞系L-02的全基因组序列,分析其基因表达差异。结果与肾癌细胞系KETR、胃癌细胞系SGC及人胎肝细胞系L-02相比,在检测的54614个探针组中,肝癌细胞系BEL7402-2表达共同上调2倍及2倍以上的有324个基因,表达下调2倍及2倍以上的有53个基因。涉及凋亡、细胞黏附、细胞增殖、信号通路等多种生物学过程。结论筛选出377个肝癌组织特异性及癌症特异性相关抗原,为进一步鉴定肝癌特异性诊断指标提供了侯选基因。 Objective To identify tissue-specific candidate genes associated with hepatocellular carcinoma(HCC). Methods The profiles of gene expression of hepatoma cell line Be17402-2 and renal carcinoma cell line, gastric carcinoma cell line, human fetal liver cells were analyzed by gene chips. Results Compared with renal carcinoma cell line, gastric carcinoma cell line, human the fetal liver cells,of the detected 54 614 probe sets, 324 genes were up-regulated by more than 2 folds and 53 genes were down-regulated by more than 2 folds in the hepatoma cell line Be17402-2, including the genes associated with apoptosis, cell adhesion,cell proliferation, and signaling pathway etc. Conclusion A total of 377 hepatoma tissue-specific and specific cancer-related genes have been screened, which provide candidate genes for further identifying specific diagnostic tumor markers for diagnosing HCC.
出处 《江苏医药》 CAS CSCD 北大核心 2009年第6期634-636,共3页 Jiangsu Medical Journal
基金 江苏省自然科学基金(BK2004013) 南京市医学科技发展项目(ZKX0401)
关键词 肝癌 候选基因 细胞株 Hepatocellular carcinoma Candidate genes Cell lines
  • 相关文献

参考文献1

二级参考文献27

  • 1Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T,Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H. Allelotype study of primary hepatocellular carcinoma.Cancer Res 1991; 51:89-93.
  • 2Wang XW, Hussain SP, Huo TI, Wu CG, Forgues M, Hofseth LJ, Brechot C, Harris CC. Molecular pathogenesis of human hepatocelluar carcinoma. Toxicology 2002; 181-182:43-47.
  • 3Okada T, Iizuka N, Yamada-Okabe H, Mori N, Tamesa T,Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y, Oka M. Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma. FEBS Lett 2003; 555:583-590.
  • 4De Souza AT, Hankins GR, Washington MK, Orton TC,Jirtle RL. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 1995;11:447-449.
  • 5Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J,Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G. Highthroughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.Am J Pathol 1999; 154:981-986.
  • 6Degot S, Regnier CH, Wendling C, Chenard MP, Rio MC,Tomasetto C. Metastatic Lymph Node 51, a novel nucleocytoplasmic protein overexpressed in breast cancer. Oncogene 2002; 21:4422-4434.
  • 7Yan HX, He YQ, Dong H, Zhang P, Zeng JZ, Cao HF, Wu MC,Wang HY. Physical and functional interaction between receptor-like protein tyrosine phosphatase PCP-2 and beta-catenin.Biochemistry 2002; 41:15854-15860.
  • 8Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ.Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res 2002;62:283-289.
  • 9Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N.Malignant transformation by a mutant of the IFN-inducibleds RNA-dependent protein kinase. Science 1992; 257:1685-1689.
  • 10Horiuchi K, Weskamp G, Lum L, Hammes HP, Cai H, Brodie TA, Ludwig T, Chiusaroli R, Baron R, Preissner KT, ManovaK, Blobel CP. Potential role for ADAM15 in pathologicalneovascul arization in mice. Mol Cell Biol 2003;23:5614-5624.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部